2-[(3S)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]acetamide
Chemical Structure Depiction of
2-[(3S)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]acetamide
2-[(3S)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]acetamide
Compound characteristics
Compound ID: | J100-0295 |
Compound Name: | 2-[(3S)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]-N-[3-(2-methyl-2H-tetrazol-5-yl)phenyl]acetamide |
Molecular Weight: | 391.39 |
Molecular Formula: | C19 H17 N7 O3 |
Smiles: | Cn1nc(c2cccc(c2)NC(C[C@H]2C(Nc3ccccc3C(N2)=O)=O)=O)nn1 |
Stereo: | ABSOLUTE |
logP: | 1.3685 |
logD: | 1.3561 |
logSw: | -2.3529 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 112.237 |
InChI Key: | PXEQCRZQOFNBLW-HNNXBMFYSA-N |